Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Explore Zero-Based Budgeting Tips For Family Finances that tighten budgeting without sacrificing essentials, helping you save more each month.
18,323 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
OneTrust’s Gabe Bodner is shifting reverse mortgage sales toward wealthy retirees, framing the product as a wealth-ma...
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Marvell Technology jumped on news it will join the S&P 500, triggering bullish moves in chips and AI infrastructure p...
Chinese humanoid makers pursue scale and government contracts even as global buyers pull back, creating a rising back...
A long-term investment thesis centers on a franchise-driven, dividend-growing fast-food operator. The 25-year hold th...
Microsoft stock sinking today has investors looking past a single bad headline. This deep-dive explains the drivers b...
Large XRP holders appear to be withdrawing from selling on major exchanges even as market volatility persists. With B...
ServiceNow is rolling out an AI-driven strategy that aims to turn it into a central control tower for enterprise work...
Micron stock losing ground sparks questions about memory cycles, AI-driven demand, and macro risks. This article brea...
As AI accelerates, two chipmakers stand out for very different reasons. This analysis weighs whether broadcom stock b...